or Try an Advanced Search...

    Technical Analysis for AZTR - Azitra Inc.

    Grade Last Price % Change Price Change
    F 0.49 -2.49% -0.01
    AZTR closed down 2.49 percent on Friday, November 1, 2024, on 26 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AZTR trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    New 52 Week Closing Low Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish -4.84%
    Inside Day Range Contraction -4.84%
    Gapped Down Weakness -4.84%
    20 DMA Resistance Bearish -4.43%
    New 52 Week Low Weakness -4.43%
    Outside Day Range Expansion -4.43%
    Older End-of-Day Signals for AZTR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 21 hours ago
    Down 1% about 21 hours ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    Possible Inside Day 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AZTR Chart by TradingView
    Basic chart:

    Profile

    Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Molecular Biology Rare Diseases Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis

    Is AZTR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 Azitra to Present at BIO-Europe 2024
    Sep 24 Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
    Sep 18 Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
    Sep 6 Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 28 Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
    Aug 23 AZTR: First ATR-12 Patient Screened
    Aug 22 Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
    Aug 21 Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Aug 20 Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
    Jul 30 AZTR: Get Some Skin in the Game
    See more AZTR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 68.4
    52 Week Low 0.46
    Average Volume 279,545
    200-Day Moving Average 6.59
    50-Day Moving Average 0.56
    20-Day Moving Average 0.53
    10-Day Moving Average 0.54
    Average True Range 0.05
    RSI (14) 36.71
    ADX 18.49
    +DI 19.45
    -DI 21.31
    Chandelier Exit (Long, 3 ATRs) 0.47
    Chandelier Exit (Short, 3 ATRs) 0.62
    Upper Bollinger Bands 0.61
    Lower Bollinger Band 0.45
    Percent B (%b) 0.21
    BandWidth 30.08
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram -0.0002
    Fundamentals Value
    Market Cap 5.87 Million
    Num Shares 12.1 Million
    EPS -1.23
    Price-to-Earnings (P/E) Ratio -0.39
    Price-to-Sales 22.01
    Price-to-Book 2.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.52
    Resistance 3 (R3) 0.53 0.52 0.52
    Resistance 2 (R2) 0.52 0.51 0.52 0.51
    Resistance 1 (R1) 0.50 0.50 0.50 0.50 0.51
    Pivot Point 0.49 0.49 0.49 0.49 0.49
    Support 1 (S1) 0.48 0.48 0.47 0.47 0.46
    Support 2 (S2) 0.47 0.48 0.47 0.46
    Support 3 (S3) 0.45 0.47 0.46
    Support 4 (S4) 0.45